Published in
Esmo Open, Esmo Open, 6(3), p. e000327, 2018
DOI: 10.1136/esmoopen-2018-000327
Links
Tools
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysis
Journal article published in 2018 by
Marina Chiara Garassino,
Tomoya Kawaguchi,
Vanesa Gregorc,
Eliana Rulli,
Masahiko Ando,
Silvia Marsoni,
Shun-Ichi Isa,
Silvia Novello,
Gabriella Farina,
Sandro Barni,
Valter Torri,
Michela Cinquini 
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 